July 23, 2014 5:08 PM ET

Biotechnology

Company Overview of Arriva Pharmaceuticals, Inc.

Executive Profile

Allan M. Wachter M.D.

Medical Director and Director, Arriva Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 0 different industries.

See Board Relationships
----

Background

Mr. Allan M. Wachter is the Medical Director and Director at Arriva Pharmaceuticals, Inc. He is a Board Certified Internist and Allergist with additional training in Molecular Biology. Dr. Wachter was the senior author on the first study on alpha 1-antitrypsin for the treatment of atopic dermatitis, published in 1992. He is a world leading authority on the clinical use of protease inhibitors for dermatological indications. Dr. Wachter is co-inventor of 15 issued U.S. ...

Corporate Headquarters

1010 Atlantic Avenue
Alameda, California 94501

United States

Phone: 510-337-1250
Fax: 510-337-1251

Board Members Memberships

Medical Director and Director

Education

There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Arriva Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.